Reinforcing its leadership in advancing healthcare and expanding access to evidence-based medical innovation, AstraZeneca Egypt & NEMAG launched the first edition of its Immuno-Oncology Summit, held in Cairo on the 2nd and the 3rdof July under the theme “Key to Life.” The summit served as a leading scientific platform, bringing together a distinguished group of oncology experts, specialists and healthcare professionals from Egypt, Iraq, Jordan, Lebanon, Libya, Palestine, Algeria, Tunisia and Morocco.
The event also created a regional forum for scientific dialogue, knowledge exchange and collaboration on the future of cancer care. Through this platform, participants shared experiences, discussed the latest scientific developments and explored opportunities to improve patient outcomes across the region.
Through a comprehensive scientific agenda featuring expert-led sessions, interactive discussions and real-world case simulations, the summit explored the latest advances in immuno-oncology and evidence-based treatment approaches for some of the most prevalent cancers, including lung, liver, biliary tract, bladder and gastric cancers. The program also highlighted patient experiences, best clinical practices and the latest therapeutic innovations, while emphasizing the importance of Multidisciplinary Teams (MDTs) in supporting personalized treatment decisions and improving collaboration across medical specialties. Discussions further explored the growing role of artificial intelligence and digital technologies in transforming cancer care.
Fostering scientific exchange and collaboration among healthcare professionals, the summit supported the advancement of clinical practice and reinforced AstraZeneca Egypt’s commitment to accelerating progress in immuno-oncology through scientific research, continuous medical education and sustainable partnerships with the healthcare community. These efforts contribute to building a more integrated healthcare ecosystem that enhances patient care and improves treatment outcomes.
Commenting on the summit, Sherif Nour, Country President of AstraZeneca Egypt, said: “At AstraZeneca, we believe that transforming cancer care requires an integrated healthcare ecosystem built on scientific innovation, continuous medical education and strong partnerships with the healthcare community. The Immuno-Oncology Summit reflects this commitment by providing a platform where eminent professors can exchange knowledge, discuss the latest scientific advances and collaborate to shape more resilient and sustainable models of care that ultimately improve patient outcomes and quality of life”.
The summit marks another milestone in AstraZeneca Egypt’s oncology strategy, reinforcing the company’s commitment to advancing scientific excellence and driving innovation in cancer care. Through strengthening collaboration across the healthcare ecosystem and supporting the adoption of the latest evidence-based practices, AstraZeneca continues to contribute to a more sustainable healthcare system that places patients at the center of care while helping build healthier communities.
